Patent application number | Description | Published |
20100273855 | COMPOSITIONS AND METHODS OF TREATING CANCER - The invention features a method for treating cancer by administering a double-stranded nucleic acid molecule against a CX gene selected from the group consisting of C14orf78, MYBL2, UBE2S and UBE2T. The invention also features products, including the double-stranded nucleic acid molecules and vectors encoding them, as well as compositions comprising the molecules or vectors, useful in the provided methods. The methods of the invention are suited for the treatment of cancers including lung cancer, breast cancer, bladder cancer, esophagus cancer, prostate cancer, cholangiocellular carcinoma and testicular seminoma. | 10-28-2010 |
20110160288 | OIP5 AS A TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS - The present invention relates to the roles played by OIP5 genes in lung and/or esophageal cancer carcinogenesis and features a method for treating and/or preventing lung and/or esophageal cancer by administering a double-stranded molecule against the OIP5 genes or a composition, vector or cell containing such a double-stranded molecule and antibody. The present invention also features methods for detecting and/or diagnosing lung and/or esophageal cancer, or assessing/determining the prognosis of and/or monitoring the efficacy of a cancer therapy in a patient with lung and/or esophageal cancer by detecting OIP5. Also, disclosed are methods of identifying compounds for treating and preventing cancer relating to OIP5. | 06-30-2011 |
20110160293 | PRMT1 FOR TARGET GENES OF CANCER THERAPY AND DIAGNOSIS - Objective methods for diagnosing a predisposition to developing cancer, particularly bladder cancer, gastric cancer, colorectal cancer, breast cancer, esophageal cancer, lung cancer, lymphoma, pancreatic cancer and testicular cancer, are described herein. In one embodiment, the diagnostic method involves determining an expression level of PRMT1 gene. The present invention further provides methods of screening for therapeutic agents useful in the treatment of PRMT1 associated disease, such as a cancer, e.g. bladder cancer, gastric cancer, colorectal cancer, breast cancer, esophageal cancer, lung cancer, lymphoma, pancreatic cancer and testicular cancer. The present invention further provides methods of inhibiting the cell growth and treating or alleviating symptoms of PRMT1 associated diseases. The present invention also features products, including double-stranded molecules and vectors encoding thereof as well as to compositions comprising them. | 06-30-2011 |
20110237518 | METHOD FOR TREATING OR PREVENTING BLADDER CANCER USING THE DEPDC1 POLYPEPTIDE - The present invention provides therapeutic agents and methods for treating cancer using the polypeptides posed of an amino acid sequence which includes a polypeptide fragment of DEPDC1. The polypeptides of the present invention can be introduced into cancer cells by modifying the polypeptides with transfection agents such as poly-arginine. Furthermore, the present invention provides methods of screening for therapeutic agents or compounds useful in inhibition of the DEPDC1/ZN-F224 complex formation or the treatment of cancer. The present invention also provides siRNAs targeting the ZNF224 gene, which are suggested to be useful in the treatment of bladder cancer. | 09-29-2011 |
20110251090 | PANCREATIC CANCER RELATED GENE TTLL4 - The present invention relates to the roles played by TTLL4 genes in pancreatic cancer carcinogenesis and features a method for treating or preventing pancreatic cancer by administering a double-stranded molecule against one or more of the TTLL4 genes or a composition, vector or cell containing such a double stranded molecule. Also, disclosed are methods of identifying compounds for treating and preventing pancreatic cancer, using as an index their effect on the over-expression of TTLL4 in the pancreatic cancer cell. | 10-13-2011 |
20110262463 | SYNGR4 FOR TARGET GENES OF CANCER THERAPY AND DIAGNOSIS - The present invention relates to the roles played by the SYNGR4 genes in lung cancer carcinogenesis and features a method for treating or preventing lung cancer by administering a double-stranded molecule against one or more of the SYNGR4 genes or a composition, vector or cell containing such a double stranded molecule and antibody. The present invention also features methods for diagnosing lung cancer or assessing/determining the prognosis of a patient with lung cancer, especially NSCLC or SCLC, using one or more over-expressed genes selected from among SYNGR4. To that end, SYNGR4 may serve as a novel serological biomarker for lung cancer. Also, disclosed are methods of identifying compounds for treating and preventing lung cancer, using as an index their effect on the over-expression of one or more of SYNGR4 in the lung cancer. | 10-27-2011 |
20110263679 | C12ORF48 AS A TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS - Objective methods for diagnosing a predisposition to developing pancreatic cancer and prostate cancer, particularly pancreatic ductal adenocarcinoma (PDAC) and castration-resistant prostate cancer, are described herein. In one embodiment, the diagnostic method involves the step of determining an expression level of C12ORF48 using siRNAs targeting the C12ORF48 gene. The invention also features products such as siRNAs as well as to compositions containing them. The present invention further provides methods of screening for therapeutic agents useful in the treatment of C12ORF48 associated disease, such as a cancer, e.g. pancreatic cancer and prostate cancer, as well as methods of inhibiting the cell growth and treating or alleviating one or more disease symptoms. The invention also features products such as double stranded molecules, as well as vectors and compositions containing them. | 10-27-2011 |
20110319280 | ECT2 ONCOGENE AS A THERAPEUTIC TARGET AND PROGNOSTIC INDICATOR FOR LUNG AND ESOPHAGEAL CANCER - The invention features methods for detecting lung cancer or esophageal cancer, by detecting over-expression of ECT2 compared the normal organs. Also disclosed are methods of identifying compounds for treating and preventing lung cancer or esophageal cancer, based on the over-expression of ECT2 in the lung cancer or esophageal cancer, the cell proliferation function of ECT2. Also, provided are a method for treating lung cancer or esophageal cancer by administering a double-stranded molecule against the ECT2 gene or an antibody against ECT2 protein. The invention also provides products, including the double-stranded molecules and vectors encoding them, as well as compositions comprising the molecules or vectors, useful in the provided methods. | 12-29-2011 |
20120010266 | TBC1D7 AS TUMOR MARKER AND THERAPEUTIC TARGET FOR CANCER - The present invention relates to the roles played by the TBC1D7 genes in cancer, in particular, lung cancer or esophageal cancer, or carcinogenesis and features a method for treating and/or preventing cancer, in particular, lung cancer or esophageal cancer by administering a double-stranded molecule against one or more of the TBC1D7 genes or a composition, vector or cell containing such a double stranded molecule. The present invention also features methods for diagnosing lung or assessing/determining the prognosis of a patient with lung, especially NSCLC or SCLC, or esophageal cancer, using one or more over-expressed genes selected from among TBC1D7. To that end, TBC1D7 may serve as a novel biomarker for lung cancer or esophageal cancer. Also, disclosed are methods of identifying compounds for treating and preventing lung or esophageal cancer, using as an index for their effect on the over-expression of one or more of TBC1D7 in the lung cancer or esophageal cancer. | 01-12-2012 |
20120022131 | BREAST CANCER RELATED GENE RQCD1 - The present invention provides methods for detecting and diagnosing cancer, such methods involving the determination of the expression level of the RQCD1, GIGYF1 or GIGYF2 genes. These genes were discovered to discriminate cancer cells from normal cells. Furthermore, the present invention provides methods of screening for therapeutic agents useful in the treatment of cancer and methods for treating cancer. Moreover, the present invention provides siRNAs targeting the RQCD1, GIGYF1 and/or GIGYF2 genes, all of which are suggested to be useful in the treatment of cancer. | 01-26-2012 |
20120128584 | ANTI-CDH3 ANTIBODIES LABELED WITH RADIOISOTOPE LABEL AND USES THEREOF - The present invention relates to anti-CDH3 antibodies, which can be labeled with a radioisotope. Moreover, the present invention provides methods and pharmaceutical compositions that comprise an anti-CDH3 antibody as an active ingredient. Since CDH3 is strongly expressed in pancreatic, lung, colon, prostate, breast, gastric or liver cancer cells, the present invention is useful in pancreatic, lung, colon, prostate, breast, gastric or liver cancer therapies. | 05-24-2012 |
Patent application number | Description | Published |
20100093390 | Mobile Radio Device - The present invention provides a portable wireless device that allows for a reduction in size of a body thereof through effective use of space inside the body by suppressing gain degradation of antennae. The portable wireless device includes: a body; a first communication unit | 04-15-2010 |
20100130140 | PORTABLE WIRELESS DEVICE - A mobile wireless device enables effective use of space in a case while reducing degradation of ah antenna gain and maintaining communication quality even if a plurality of antennas having different frequency bands are arranged close to one another. A magnetic antenna has a first switch unit, a second switch unit, and a concentrated constant circuit which are added to a wiring pattern at the side near to a main antenna, so that a first path and a second path can be selected. Under a predetermined condition, a CPU controls the first switch and the second switch to electrically connect a terminal (A | 05-27-2010 |
20110199283 | PORTABLE ELECTRONIC DEVICE - A portable electronic device is provided that is capable of reducing the degradation in the characteristic of an antenna caused by the orientation direction of the antenna being fixed. The device includes a circuit board disposed in the vicinity of an antenna, a conductive switch terminal that is provided to the circuit board and detects an operation to an operation unit, a reference potential part provided to the circuit board to be opposite to the switch terminal, a conductive part provided to the circuit board to be opposite to the antenna, and a switch unit capable of switching whether the reference potential part and the conductive part are electrically connected. | 08-18-2011 |
20110273357 | PORTABLE TERMINAL - Provided is a portable terminal wherein reduction of an antenna gain can be suitably suppressed. The portable terminal is provided with a circuit section ( | 11-10-2011 |
20120019996 | PORTABLE TERMINAL - Provided is a portable terminal wherein reception sensitivity can be easily adjusted. A portable terminal is provided with an operating section side case section ( | 01-26-2012 |
20120162033 | ELECTRONIC DEVICE - An electronic device includes: an antenna; and a touch panel having an electrode sheet formed with an operation detecting pattern, which has conductive, wherein an antenna pattern configuring the antenna is formed on the periphery of the touch panel. | 06-28-2012 |
20120194394 | PORTABLE ELECTRONIC DEVICE - To provide a portable electronic device that includes an antenna that has a novel configuration that uses a conductive portion. The portable electronic device includes an operation unit side body that has a first conductive portion; a display unit side body that has a second conductive portion; a connecting portion that has a third conductive portion, and connects the operation unit side body and the display unit side body to enable transition between a closed state and an opened state; and a power feed unit. The cellular telephone device enables operation as a magnetic current antenna by power supply from a power feed unit to an opposed region that is formed by enclosure of at least three sides by the first conductive portion, the second conductive portion, and the third conductive portion. | 08-02-2012 |
Patent application number | Description | Published |
20120086845 | SOLID-STATE IMAGING DEVICE, METHOD OF MANUFACTURING SOLID-STATE IMAGING DEVICE, AND ELECTRONIC APPARATUS - A solid-state imaging device includes a substrate, a through-hole, a vertical gate electrode, and a charge fixing film. A photoelectric conversion unit generating signal charges in accordance with the amount of received light is formed in the substrate. The through-hole is formed from a front surface side through a rear surface side of the substrate. The vertical gate electrode is formed through a gate insulating film in the through-hole and reads out the signal charges generated by the photoelectric conversion unit to a reading-out portion. The charge fixing film has negative fixed charges formed to cover a portion of the inner circumferential surface of the through-hole at the rear surface side of the substrate while covering the rear surface side of the substrate. | 04-12-2012 |
20120217558 | IMAGING DEVICE, METHOD OF MANUFACTURING THE SAME, AND ELECTRONIC APPARATUS - A solid-state imaging device includes: a substrate which is formed of a semiconductor and includes a first surface and a second surface which face opposite sides; a gate insulation film which is formed on a trench formed in the substrate to penetrate the first surface and the second surface; and a gate electrode which is embedded in the trench through the gate insulation film to be exposed to a second surface side of the substrate. A step difference is formed from the second surface of the substrate to a tip end surface of the gate electrode on the second surface side. | 08-30-2012 |
20130015513 | SOLID-STATE IMAGING DEVICE, SOLID-STATE IMAGING DEVICE MANUFACTURING METHOD, AND ELECTRONIC DEVICEAANM Kido; HideoAACI KanagawaAACO JPAAGP Kido; Hideo Kanagawa JPAANM Enomoto; TakayukiAACI KanagawaAACO JPAAGP Enomoto; Takayuki Kanagawa JPAANM Togashi; HideakiAACI KanagawaAACO JPAAGP Togashi; Hideaki Kanagawa JP - A solid-state imaging device includes: a first photodiode made up of a first first-electroconductive-type semiconductor region formed on a first principal face side of a semiconductor substrate, and a first second-electroconductive-type semiconductor region formed within the semiconductor substrate adjacent to the first first-electroconductive-type semiconductor region; a second photodiode made up of a second first-electroconductive-type semiconductor region formed on a second principal face side of the semiconductor substrate, and a second second-electroconductive-type semiconductor region formed within the semiconductor substrate adjacent to the second first-electroconductive-type semiconductor region; and a gate electrode formed on the first principal face side of the semiconductor substrate; with impurity concentration of a connection face between the second first-electroconductive-type semiconductor region and the second second-electroconductive-type semiconductor region being equal to or greater than impurity concentration of a connection face of an opposite layer of the second first-electroconductive-type semiconductor region of the second second-electroconductive-type semiconductor region. | 01-17-2013 |
20130109072 | SUPPORT FOR PROTEIN IMMOBILIZATION, IMMOBILIZED PROTEIN, AND METHODS FOR PRODUCING THE SAME | 05-02-2013 |
20140080252 | SOLID-STATE IMAGING DEVICE, METHOD OF MANUFACTURING SOLID-STATE IMAGING DEVICE, AND ELECTRONIC APPARATUS - A solid-state imaging device including a substrate, a through-hole, a vertical gate electrode, and a charge fixing film. A photoelectric conversion unit generating signal charges in accordance with the amount of received light is formed in the substrate. The through-hole is formed from a front surface side through a rear surface side of the substrate. The vertical gate electrode is formed through a gate insulating film in the through-hole and reads out the signal charges generated by the photoelectric conversion unit to a reading-out portion. The charge fixing film has negative fixed charges formed to cover a portion of the inner circumferential surface of the through-hole at the rear surface side of the substrate while covering the rear surface side of the substrate. | 03-20-2014 |
Patent application number | Description | Published |
20090207704 | Recording apparatus, server apparatus, recording method, program, and storage medium - A data recording apparatus recording data of a CD on an HDD in a manner such that the content of record in the CD is faithfully accounted for and shortening an operation time for a synchronized ripping operation. When the data recording apparatus reads, from the CD, track data managed by track, according to TOC, and records the track data onto the HDD, the data recording apparatus recognizes data unrecorded on the HDD, from among the track data recorded on the CD. This recognition process is automatically performed based on the TOC read from the CD, and album information replayed using the TOC and held by the HDD. The recording apparatus reproduces and outputs only the unrecorded data from the CD based on the recognition result concerning the unrecorded data. In this way, the data already recorded on the HDD is not transferred from the CD to the HDD. The operation time for the synchronized ripping operation is reduced accordingly. | 08-20-2009 |
20110109985 | RECORDING APPARATUS, SERVER APPARATUS, RECORDING METHOD, PROGRAM, AND STORAGE MEDIUM - A data recording apparatus recording data of a CD on an HDD in a manner such that the content of record in the CD is faithfully accounted for and shortening an operation time for a synchronized ripping operation. When the data recording apparatus reads, from the CD, track data managed by track, according to TOC, and records the track data onto the HDD, the data recording apparatus recognizes data unrecorded on the HDD, from among the track data recorded on the CD. This recognition process is automatically performed based on the TOC read from the CD, and album information replayed using the TOC and held by the HDD. The recording apparatus reproduces and outputs only the unrecorded data from the CD based on the recognition result concerning the unrecorded data. In this way, the data already recorded on the HDD is not transferred from the CD to the HDD. The operation time for the synchronized ripping operation is reduced accordingly. | 05-12-2011 |
20130100785 | RECORDING APPARATUS, SERVER APPARATUS, RECORDING METHOD, PROGRAM AND STORAGE MEDIUM - An information processing apparatus including a reading unit, a processor, a transferring unit, and a control unit. The reading unit reads first management data from a first recording medium. The first management data identifies tracks of source data recorded on the first recording medium. The processor compares the first management data with second management data. The second management data identifies files of ripped data recorded on a second recording medium. The transferring unit transfers one of the tracks of the source data, to the second recording medium, when absent from the second recording medium. The control unit controls a display unit to display transferring status by a symbolic figure. | 04-25-2013 |
20140146651 | RECORDING APPARATUS, SERVER APPARATUS, RECORDING METHOD, PROGRAM AND STORAGE MEDIUM - A non-transitory computer-readable storage medium and information processing apparatuses. The medium stores instructions which, when executed by a computer, cause the computer to perform a method including automatically reading first management data from a first recording medium. The first management data identifies tracks of source data recorded on the first recording medium. One of the tracks of source data is automatically identified based on the first management data and second management data, which identifies files of ripped data recorded on a second recording medium. The one of the tracks of source data is absent from the second recording medium. The one of the tracks of source data is automatically transferred to the second recording medium and becomes one of the files of ripped data. The method further includes automatically displaying transferring status of the one of the tracks of source data by a symbolic figure. | 05-29-2014 |